D. W. E. Wicker
Fondateur chez Panorama Capital LLC
Profil
D.
W.
E.
Wicker is the founder of Panorama Capital LLC, which was founded in 2005.
He holds the title of Managing Director at Panorama Capital LLC starting in 2006.
Dr. Wicker currently holds the position of Director at Cadent Holdings, Inc. and Member-Investment Committee at The New York Academy of Medicine.
Dr. Wicker has held former positions as Director at Lifecore Biomedical, Inc., Innotech, Inc., Genomic Solutions, Inc., DJO Opco Holdings, Inc., Phenomix Corp., Oldtech, Inc., ProRhythm, Inc., and Renovo Ltd.
He was also a Partner at J.P.
Morgan Partners LLC from 1993 to 2004 and held the title of Principal at Alexon Biomedical, Inc. Dr. Wicker's education history includes an MBA from the University of Pennsylvania, an undergraduate degree from the Massachusetts Institute of Technology, and a doctorate from The Johns Hopkins University.
Postes actifs de D. W. E. Wicker
| Sociétés | Poste | Début |
|---|---|---|
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Fondateur | 01/01/2006 |
Cadent Holdings, Inc.
 Cadent Holdings, Inc. Medical SpecialtiesHealth Technology Headquartered in Carlstadt, New Jersey and with a development center in Tel Aviv, Israel, Cadent is the leading provider of 3-D digital solutions for the orthodontic and dental industries. The company services thousands of cases each day for a rapidly expanding customer base. Cadent's offerings improve the efficiency and effectiveness of orthodontic and dental treatments while increasing the revenue of dental healthcare providers. The company is backed by a consortium of leading venture capital investors including Apax Partners, Panorama Capital (J.P. Morgan Partners), Pitango Venture Capital, STAR Ventures, and SV Life Sciences. | Directeur/Membre du Conseil | - |
The New York Academy of Medicine
 The New York Academy of Medicine Miscellaneous Commercial ServicesCommercial Services The New York Academy of Medicine (NYAM) is a leading advocate for innovation in public health. The non-profit company is based in New York, NY and has subsidiaries in the United States. For 176 years, NYAM has been at the forefront of promoting bold changes to the systems that perpetuate health inequities and prevent communities from achieving good health. NYAM's work includes innovative research, programs, and policy initiatives that value community input for maximum impact. NYAM's library is one of the most significant historical libraries in medicine and public health in the nation, with an extensive range of recommended resources available. | Corporate Officer/Principal | - |
Anciens postes connus de D. W. E. Wicker
| Sociétés | Poste | Fin |
|---|---|---|
| Innotech, Inc. | Directeur/Membre du Conseil | 17/03/2011 |
Renovo Ltd.
 Renovo Ltd. Pharmaceuticals: MajorHealth Technology Renovo Plc manufactures and distributes pharmaceutical products. The biopharmaceutical company develops novel pharmaceuticals products to prevent and reduce scarring in the skin, cardiovascular system, eye, central nervous system, internal adhesions, ligaments and systemic fibrotic disorders. The company was founded in 2000 and is headquartered in Manchester, United Kingdom. | Directeur/Membre du Conseil | 16/02/2011 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection. The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force. | Directeur/Membre du Conseil | 28/10/2010 |
DJO Opco Holdings, Inc.
 DJO Opco Holdings, Inc. Medical SpecialtiesHealth Technology DJO Opco Holdings, Inc. manufactures and supplies surgical and non-surgical products and services that regenerate and repair soft tissues and bones. It markets its products under brand names such as DonJoy, OfficeCare, and ProCare including rigid knee braces and soft goods. The company markets its products to the surgeons, hospitals, physical therapists, athletic trainers, and other health care professionals. The company is headquartered in Vista, CA. | Directeur/Membre du Conseil | 20/11/2007 |
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners LLC is a private equity firm founded in 1984. The firm headquartered located in New York City. | Private Equity Investor | 31/12/2004 |
Formation de D. W. E. Wicker
| University of Pennsylvania | Masters Business Admin |
| Massachusetts Institute of Technology | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LIFECORE BIOMEDICAL, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
| Innotech, Inc. | Technology Services |
Genomic Solutions, Inc.
 Genomic Solutions, Inc. Packaged SoftwareTechnology Services Genomic Solutions, Inc. designs, develops genomic and proteomic instrumentation software solutions. It provides cell based assays, gene expression analysis, array hybridization, drug discovery and assay assembly. The company was founded by Jeffrey S. Williams in 1997 and is headquartered in Ann Arbor, MI. | Technology Services |
DJO Opco Holdings, Inc.
DJO Opco Holdings, Inc. Medical SpecialtiesHealth Technology DJO Opco Holdings, Inc. manufactures and supplies surgical and non-surgical products and services that regenerate and repair soft tissues and bones. It markets its products under brand names such as DonJoy, OfficeCare, and ProCare including rigid knee braces and soft goods. The company markets its products to the surgeons, hospitals, physical therapists, athletic trainers, and other health care professionals. The company is headquartered in Vista, CA. | Health Technology |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection. The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force. | Health Technology |
Cadent Holdings, Inc.
Cadent Holdings, Inc. Medical SpecialtiesHealth Technology Headquartered in Carlstadt, New Jersey and with a development center in Tel Aviv, Israel, Cadent is the leading provider of 3-D digital solutions for the orthodontic and dental industries. The company services thousands of cases each day for a rapidly expanding customer base. Cadent's offerings improve the efficiency and effectiveness of orthodontic and dental treatments while increasing the revenue of dental healthcare providers. The company is backed by a consortium of leading venture capital investors including Apax Partners, Panorama Capital (J.P. Morgan Partners), Pitango Venture Capital, STAR Ventures, and SV Life Sciences. | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
ProRhythm, Inc.
 ProRhythm, Inc. Medical SpecialtiesHealth Technology ProRhythm, Inc. provides medical services. It developed HIFU (High Intensity Focused Ultrasound) for the treatment of atrial fibrillation (AF) a debilitating arrhythmia. The company was founded by David E. Acker in 1997 and is headquartered in Ronkonkoma, NY. | Health Technology |
J.P. Morgan Partners LLC
J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners LLC is a private equity firm founded in 1984. The firm headquartered located in New York City. | Finance |
Renovo Ltd.
Renovo Ltd. Pharmaceuticals: MajorHealth Technology Renovo Plc manufactures and distributes pharmaceutical products. The biopharmaceutical company develops novel pharmaceuticals products to prevent and reduce scarring in the skin, cardiovascular system, eye, central nervous system, internal adhesions, ligaments and systemic fibrotic disorders. The company was founded in 2000 and is headquartered in Manchester, United Kingdom. | Health Technology |
The New York Academy of Medicine
The New York Academy of Medicine Miscellaneous Commercial ServicesCommercial Services The New York Academy of Medicine (NYAM) is a leading advocate for innovation in public health. The non-profit company is based in New York, NY and has subsidiaries in the United States. For 176 years, NYAM has been at the forefront of promoting bold changes to the systems that perpetuate health inequities and prevent communities from achieving good health. NYAM's work includes innovative research, programs, and policy initiatives that value community input for maximum impact. NYAM's library is one of the most significant historical libraries in medicine and public health in the nation, with an extensive range of recommended resources available. | Commercial Services |
Panorama Capital LLC
Panorama Capital LLC Investment ManagersFinance Panorama Capital LLC (Panorama Capita) is a venture capital firm founded in 1995 by Chris Albinson, Rod Ferguson, Shahan Soghikian and damion wicker. The firm is headquartered in Campbell, California. | Finance |
Alexon Biomedical, Inc.
 Alexon Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Alexon Biomedical, Inc. manufactures pharmaceutical products. The private company is based in Mountain View, CA. | Health Technology |
